ARUP Test Code

0050175

Performed

Tue, Thu, Sat

Reported

2-7 days

Interpretive Data

Titers of 1:32 or higher are considered elevated by this technique. Elevated titers are rarely seen except in primary atypical pneumonia and in certain hemolytic anemias. If the agglutination is not reversible after incubation at 37°C, then the reaction is not due to cold agglutinins.

Primary atypical pneumonia can be caused by Mycoplasma pneumoniae, influenza A, influenza B, parainfluenza, and adenoviruses. However, a fourfold rise in the cold agglutinins usually begins to appear late in the first week or during the second week of the disease and begins to decrease between the fourth and sixth weeks.  Low titers of cold agglutinins have been demonstrated in malaria, peripheral vascular disease, and common respiratory disease.

Referral Lab

Collect

Serum separator tube or plain red.

Minimum Collection Volume

0.7 mL

Specimen Preparation

Keep in warm water (37°C) until processed for transport by laboratory; refrigeration of specimen before separation of serum from cells will adversely affect test results. Transfer 1 mL serum to an ARUP standard transport tube. (Min: 0.25 mL)

Unacceptable Conditions

Plasma or CSF. Refrigerated whole blood. Contaminated, severely hemolyzed, or lipemic, specimens.

Storage/Transport Temperature

Refrigerated.

Stability (from collection to initiation)

After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)

Containers

Red or Gold (Gel)/SST

Alternate Containers

Red (No Gel)

Reference Interval

< 1:32 Negative

Interpretive Data

Titers of 1:32 or higher are considered elevated by this technique. Elevated titers are rarely seen except in primary atypical pneumonia and in certain hemolytic anemias. If the agglutination is not reversible after incubation at 37°C, then the reaction is not due to cold agglutinins.

Primary atypical pneumonia can be caused by Mycoplasma pneumoniae, influenza A, influenza B, parainfluenza, and adenoviruses. However, a fourfold rise in the cold agglutinins usually begins to appear late in the first week or during the second week of the disease and begins to decrease between the fourth and sixth weeks.  Low titers of cold agglutinins have been demonstrated in malaria, peripheral vascular disease, and common respiratory disease.

CPT Disclaimer

The Current Procedural Terminology (CPT) Codes published in the M Health Fairview Test Directory are based on American Medical Association (AMA) guidelines and are provided for informational purposes only. CPT codes are provided only as guidance to assist clients with billing. CPT coding is the responsibility of the billing party. M Health Fairview Laboratories does not assume responsibility for billing errors due to reliance on the CPT codes listed in Test Directory or Atlas. Charges may vary due to reflexing, susceptibilities, specimen source, patient age, methodology requirements, etc.

Patient Price Inquiries

Requester Contact Information
Patient and UMP/FV Care Team Fairview Consumer Line at 612-672-1048
MRL Outreach Client dept-mrl-business-assessment@fairview.org
Research research@fairview.org

Billing Information

CPTQtyHC HospitalPR ClinicNote
86157130086157028615701HC COLD AGGLUTININ TITER

CPT Codes

86157

Methodology

Semi-Quantitative Hemagglutination (HA)

MRL Test Build

Test Name Component Required Description Type LOINC
LAB849     Cold Agglutinin Titer Orderable  
  SRC_1001 Y Blood specimen source: Prompt  
  1231000367   Cold Agglutinins Result 5098-9

Data Type / Multiple Choice Response

SRC_1001
Blood specimen source:
Arm, Left|Arm, Right|Hand, Left|Hand, Right|Blood, Capillary|Other|Peripheral Blood
Default: Peripheral Blood

Contact

For questions regarding the test code Interface Map, please contact DEPT-LAB-CLIENT-INTERFACE@fairview.org
Ordering

ARUP Test Code

0050175

Performed

Tue, Thu, Sat

Reported

2-7 days

Interpretive Data

Titers of 1:32 or higher are considered elevated by this technique. Elevated titers are rarely seen except in primary atypical pneumonia and in certain hemolytic anemias. If the agglutination is not reversible after incubation at 37°C, then the reaction is not due to cold agglutinins.

Primary atypical pneumonia can be caused by Mycoplasma pneumoniae, influenza A, influenza B, parainfluenza, and adenoviruses. However, a fourfold rise in the cold agglutinins usually begins to appear late in the first week or during the second week of the disease and begins to decrease between the fourth and sixth weeks.  Low titers of cold agglutinins have been demonstrated in malaria, peripheral vascular disease, and common respiratory disease.

Referral Lab

Collection & Processing

Collect

Serum separator tube or plain red.

Minimum Collection Volume

0.7 mL

Specimen Preparation

Keep in warm water (37°C) until processed for transport by laboratory; refrigeration of specimen before separation of serum from cells will adversely affect test results. Transfer 1 mL serum to an ARUP standard transport tube. (Min: 0.25 mL)

Unacceptable Conditions

Plasma or CSF. Refrigerated whole blood. Contaminated, severely hemolyzed, or lipemic, specimens.

Storage/Transport Temperature

Refrigerated.

Stability (from collection to initiation)

After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Containers

Containers

Red or Gold (Gel)/SST

Alternate Containers

Red (No Gel)

Result Interpretation

Reference Interval

< 1:32 Negative

Interpretive Data

Titers of 1:32 or higher are considered elevated by this technique. Elevated titers are rarely seen except in primary atypical pneumonia and in certain hemolytic anemias. If the agglutination is not reversible after incubation at 37°C, then the reaction is not due to cold agglutinins.

Primary atypical pneumonia can be caused by Mycoplasma pneumoniae, influenza A, influenza B, parainfluenza, and adenoviruses. However, a fourfold rise in the cold agglutinins usually begins to appear late in the first week or during the second week of the disease and begins to decrease between the fourth and sixth weeks.  Low titers of cold agglutinins have been demonstrated in malaria, peripheral vascular disease, and common respiratory disease.

Administrative

CPT Disclaimer

The Current Procedural Terminology (CPT) Codes published in the M Health Fairview Test Directory are based on American Medical Association (AMA) guidelines and are provided for informational purposes only. CPT codes are provided only as guidance to assist clients with billing. CPT coding is the responsibility of the billing party. M Health Fairview Laboratories does not assume responsibility for billing errors due to reliance on the CPT codes listed in Test Directory or Atlas. Charges may vary due to reflexing, susceptibilities, specimen source, patient age, methodology requirements, etc.

Patient Price Inquiries

Requester Contact Information
Patient and UMP/FV Care Team Fairview Consumer Line at 612-672-1048
MRL Outreach Client dept-mrl-business-assessment@fairview.org
Research research@fairview.org

Billing Information

CPTQtyHC HospitalPR ClinicNote
86157130086157028615701HC COLD AGGLUTININ TITER

CPT Codes

86157

Methodology

Semi-Quantitative Hemagglutination (HA)
Interface Mapping

MRL Test Build

Test Name Component Required Description Type LOINC
LAB849     Cold Agglutinin Titer Orderable  
  SRC_1001 Y Blood specimen source: Prompt  
  1231000367   Cold Agglutinins Result 5098-9

Data Type / Multiple Choice Response

SRC_1001
Blood specimen source:
Arm, Left|Arm, Right|Hand, Left|Hand, Right|Blood, Capillary|Other|Peripheral Blood
Default: Peripheral Blood

Contact

For questions regarding the test code Interface Map, please contact DEPT-LAB-CLIENT-INTERFACE@fairview.org
Private Details